Data quality monitoring in clinical trials: Has it been worth it? an evaluation and prediction of the future by all stakeholders

Innovations in Clinical Neuroscience

Volumn 13, Issue 1-2, 2016, Pages 27-33

  Daniel, David ^a   Kalali, Amir ^b   West, Mark ^c   Walling, David ^d   Hilt, Dana ^e   Engelhardt, Nina ^f   Alphs, Larry ^g   Loebel, Antony ^h   Vanover, Kim ⁱ   Atkinson, Sarah ^j   Opler, Mark ^k   Sachs, Gary ^l   Nations, Kari ^m   Brady, Chris ^m  

^a Bracket Global   (United States)

^b IQVIA   (United States)

^c Innovum Technologies   (United States)

^d Collaborative Neuroscience Network ^*  (United States)

^e FORUM Pharmaceuticals   (United States)

^f Cronos   (United States)

^g JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^h DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

ⁱ Intra Cellular Therapies Inc   (United States)

^j Finger Lakes Clinical Research   (United States)

^k ProPhase LLC   (United States)

^l Bracket   (United States)

^m SYNEOS HEALTH   (United States)

more..

Author keywords

Clinical trial methodology; Clinical trials; CNS; Data monitoring; Data quality; Drug development; Trial design

Indexed keywords

CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; DRUG INDUSTRY; FEMALE; HUMAN; MALE; MONITORING; PATIENT SELECTION; PREDICTION; STUDY DESIGN;

EID: 85027576710     PISSN: 21588333     EISSN: 21588341     Source Type: Journal    
DOI: None     Document Type: Article

References (0)